Interaction between a heme oxygenase-1 gene promoter polymorphism and serum β-carotene levels on 8-year lung function decline in a general population: The European Community Respiratory Health Survey (France)

American Journal of Epidemiology

Volumn 167, Issue 2, 2008, Pages 139-144

  Guenegou, Armelle ^a   Boczkowski, Jorge ^a   Aubier, Michel ^a   Neukirch, Françoise ^a   Leynaert, Bénédicte ^a  

^a INSERM   (France)

Author keywords

Beta carotene; Follow up studies; France; Heme oxygenase 1; Polymorphism, genetic; Pulmonary disease, chronic obstructive; Serum; Spirometry

Indexed keywords

BETA CAROTENE; HEME OXYGENASE 1;

GENE; GENETICS; HEALTH SURVEY; PATHOGEN; POLYMORPHISM; RESPIRATORY DISEASE;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE INTERACTION; GENETIC POLYMORPHISM; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK FACTOR;

EURASIA; EUROPE; FRANCE; WESTERN EUROPE;

EID: 38349105917     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm282     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Birmingham, AL: GOLD, Lung Health Center, University of Alabama, 2006. (http://www.goldcopd.com/GuidelinesResources.asp?l1=2&l2=0). (Accessed May 27, 2007).
3. Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000;66:187-95.
4. Guénégou A, Leynaert B, Bénessiano J, et al. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet 2006;43:e43.
5. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000;151:975-81.
6. Guénégou A, Leynaert B, Pin I, et al. Serum carotenoids, vitamins A and E and 8-year lung function decline in a general population. Thorax 2006;61:320-6.
7. The European Community Respiratory Health Survey Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002;20:1071-9.
8. Exner M, Minar E, Wagner O, et al. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004;37:1097-104.
9. He JQ, Ruan J, Connett JE, et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002;166:323-8.
10. Kikuchi A, Yamaya M, Suzuki S, et al. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 2005;116:354-60.
11. Fu WP, Zhao ZH, Fang LZ, et al. Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease. Chin Med J (Engl) 2007;120:12-16.
12. Hosaka S, Obuki M, Nakajima J, et al. Comparative study of antioxidants as quenchers or scavengers of reactive oxygen species based on quenching of MCLA-dependent chemiluminescence. Luminescence 2005;20:419-27.
13. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 2000;28:289-309.
14. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000;151:975-81.
15. Kelly Y, Sacker A, Marmot M. Nutrition and respiratory health in adults: findings from the health survey for Scotland. Eur Respir J 2003;21:664-71.
16. Schünemann HJ, Grant BJ, Freudenheim JL, et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 2001;163:1246-55.
17. Northrop-Clewes CA, Thurnham DI. Monitoring micronutrients in cigarette smokers. Clin Chim Acta 2007;377:14-38.
18. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996;16:33-50.
19. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. CMAJ 2000;163:739-44.
20. Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition 2002;18:872-9.
21. Olmedilla B, Granado F, Southon S, et al. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. Br J Nutr 2001;85:227-38.
22. Hunter D. Biochemical indicators of dietary intake. In: Willett W, ed. Nutritional epidemiology. New York, NY: Oxford University Press, 1998.
23. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002;180:121-37.
24. Cauchi S, Meyre D, Choquet H, et al. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study. Diabetes 2006;55:3189-92.
25. de Lauzon-Guillain B, Basdevant A, Romon M, et al. Is restrained eating a risk factor for weight gain in a general population? Am J Clin Nutr 2006;83:132-8.
26. Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 1976;5:299-311.
27. WHO Regional Office for Europe. Tobacco control database. Geneva, Switzerland: World Health Organization, 2007. (http://data.euro.who.int/tobacco/ ). (Accessed June 12, 2007).
28. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1:1645-8.
29. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-9.
30. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
31. Lange P, Groth S, Nyboe J, et al. Decline of the lung function related to the type of tobacco smoked and inhalation. Thorax 1990;45:22-6.
32. Xu X, Dockery DW, Ware JH, et al. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992;146:1345-8.
33. Sherman CB, Xu X, Speizer FE, et al. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;146:855-9.
34. Working Group on Action to Control Chemicals. Minutes of the 2nd meeting of the Working Group on Action to Control Chemicals (WATCH) held on 10th June 2004. Minutes, 2004. London, United Kingdom: Health and Safety Commission, 2004. (www.hse.gov.uk/aboutus/hsc/iacs/acts/watch/100604/Minutes.pdf).